Niu J - Search Results

1

aMAP risk score predicts hepatocellular carcinoma development in patients with chronic hepatitis.

Fan R, Papatheodoridis G, Sun J, Innes H, Toyoda H, Xie Q, Mo S, Sypsa V, Guha IN, Kumada T, Niu J, Dalekos G, Yasuda S, Barnes E, Lian J, Suri V, Idilman R, Barclay ST, Dou X, Berg T, Hayes PC, Flaherty JF, Zhou Y, Zhang Z, Buti M, Hutchinson SJ, Guo Y, Calleja JL, Lin L, Zhao L, Chen Y, Janssen HLA, Zhu C, Shi L, Tang X, Gaggar A, Wei L, Jia J, Irving WL, Johnson PJ, Lampertico P, Hou J. Fan R, et al. Among authors: niu j. J Hepatol. 2020 Dec;73(6):1368-1378. doi: 10.1016/j.jhep.2020.07.025. Epub 2020 Jul 21. J Hepatol. 2020. PMID: 32707225 Free article.

2

[Distribution and clinical significance of hepatitis B virus (HBV) genotypes and subtypes in HBV-infected patients].

Li YJ, Zhuang H, Li J, Dong QM, Chen YJ, Niu JQ, Ma WM, Zhao W, Zhao BA, Zhong JQ. Li YJ, et al. Among authors: niu jq. Zhonghua Gan Zang Bing Za Zhi. 2005 Oct;13(10):724-9. Zhonghua Gan Zang Bing Za Zhi. 2005. PMID: 16248941 Chinese.

3

[A study of 10-23 DNAzyme inhibiting the expression of hepatitis B virus genes].

Ren N, Wang F, Niu JQ. Ren N, et al. Zhonghua Gan Zang Bing Za Zhi. 2005 Oct;13(10):745-8. Zhonghua Gan Zang Bing Za Zhi. 2005. PMID: 16248946 Chinese.

4

[A multicenter, randomized, open-label study of the safety and effectiveness of pegylated interferon alpha 2b and interferon alpha 2b in treating HBeAg positive chronic hepatitis B patients].

Zhao H, Si CW, Wei L, Wan MB, Ying YK, Hou JL, Niu JQ. Zhao H, et al. Zhonghua Gan Zang Bing Za Zhi. 2006 May;14(5):323-6. Zhonghua Gan Zang Bing Za Zhi. 2006. PMID: 16732903 Clinical Trial. Chinese.

5

Genotype B and younger patient age associated with better response to low-dose therapy: a trial with pegylated/nonpegylated interferon-alpha-2b for hepatitis B e antigen-positive patients with chronic hepatitis B in China.

Zhao H, Kurbanov F, Wan MB, Yin YK, Niu JQ, Hou JL, Wei L, Wang GQ, Tanaka Y, Mizokami M, Si CW. Zhao H, et al. Clin Infect Dis. 2007 Feb 15;44(4):541-8. doi: 10.1086/511042. Epub 2007 Jan 11. Clin Infect Dis. 2007. PMID: 17243057 Clinical Trial.

6

[The degree of HBV suppression with 24 week telbivudine- or lamivudine-treatment in hepatitis B patients predicts the efficacy of the treatment at week 52].

Jia JD, Hou JL, Yin YK, Xu DZ, Tan DM, Niu JQ, Zhou XQ, Wang YM, Zhu LM, He YW, Ren H, Wan MB, Chen CW, Wu SM, Chen YG, Xu JZ, Wang QH, Wei L, Ma H. Jia JD, et al. Zhonghua Gan Zang Bing Za Zhi. 2007 May;15(5):342-5. Zhonghua Gan Zang Bing Za Zhi. 2007. PMID: 17524265 Clinical Trial. Chinese.

7

Telbivudine versus lamivudine in Chinese patients with chronic hepatitis B: Results at 1 year of a randomized, double-blind trial.

Hou J, Yin YK, Xu D, Tan D, Niu J, Zhou X, Wang Y, Zhu L, He Y, Ren H, Wan M, Chen C, Wu S, Chen Y, Xu J, Wang Q, Wei L, Chao G, Constance BF, Harb G, Brown NA, Jia J. Hou J, et al. Among authors: niu j. Hepatology. 2008 Feb;47(2):447-54. doi: 10.1002/hep.22075. Hepatology. 2008. PMID: 18080339 Clinical Trial.

8

Efficacy and safety of prolonged 3-year telbivudine treatment in patients with chronic hepatitis B.

Gane EJ, Wang Y, Liaw YF, Hou J, Thongsawat S, Wan M, Moon YM, Jia J, Chao YC, Niu J, Leung N, Samuel D, Hsu CW, Bao W, Lopez P, Avila C. Gane EJ, et al. Among authors: niu j. Liver Int. 2011 May;31(5):676-84. doi: 10.1111/j.1478-3231.2011.02490.x. Epub 2011 Mar 16. Liver Int. 2011. PMID: 21457439 Clinical Trial.

9

[Recent development of the application of metabolomics in liver diseases].

Niu LL, Niu JQ. Niu LL, et al. Zhonghua Gan Zang Bing Za Zhi. 2012 Aug;20(8):634-5. Zhonghua Gan Zang Bing Za Zhi. 2012. PMID: 23227536 Review. Chinese. No abstract available.

10

Antiviral treatment alters the frequency of activating and inhibitory receptor-expressing natural killer cells in chronic hepatitis B virus infected patients.

Lv J, Jin Q, Sun H, Chi X, Hu X, Yan H, Pan Y, Xiao W, Tian Z, Hou J, Xu D, Tu Z, Niu J. Lv J, et al. Among authors: niu j. Mediators Inflamm. 2012;2012:804043. doi: 10.1155/2012/804043. Epub 2012 Dec 10. Mediators Inflamm. 2012. PMID: 23304062 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,991 results

Search Page

Filters